Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Animal models

Decreased cell stiffness enhances leukemia development and progression

Subjects

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Deletion of Ptpn21 promotes development and progression of MLL-AF9-induced leukemia.
Fig. 2: Cellular mechanical properties but not cell signaling activities are impacted in Ptpn21-deleted MLL leukemic cells that proliferate faster than control cells in vivo.

References

  1. 1.

    Fletcher DA, Mullins RD. Cell mechanics and the cytoskeleton. Nature. 2010;463:485–92.

    CAS  Article  Google Scholar 

  2. 2.

    Tse HT, Gossett DR, Moon YS, Masaeli M, Sohsman M, Ying Y, et al. Quantitative diagnosis of malignant pleural effusions by single-cell mechanophenotyping. Sci Transl Med. 2013;5:212ra163.

    Article  Google Scholar 

  3. 3.

    Byun S, Son S, Amodei D, Cermak N, Shaw J, Kang JH, et al. Characterizing deformability and surface friction of cancer cells. Proc Natl Acad Sci USA. 2013;110:7580–5.

    CAS  Article  Google Scholar 

  4. 4.

    Cross SE, Jin YS, Rao J, Gimzewski JK. Nanomechanical analysis of cells from cancer patients. Nat Nanotechnol. 2007;2:780–3.

    CAS  Article  Google Scholar 

  5. 5.

    Plodinec M, Loparic M, Monnier CA, Obermann EC, Zanetti-Dallenbach R, Oertle P, et al. The nanomechanical signature of breast cancer. Nat Nanotechnol. 2012;7:757–65.

    CAS  Article  Google Scholar 

  6. 6.

    Moller NP, Moller KB, Lammers R, Kharitonenkov A, Sures I, Ullrich A. Src kinase associates with a member of a distinct subfamily of protein-tyrosine phosphatases containing an ezrin-like domain. Proc Natl Acad Sci USA. 1994;91:7477–81.

    CAS  Article  Google Scholar 

  7. 7.

    Carlucci A, Gedressi C, Lignitto L, Nezi L, Villa-Moruzzi E, Avvedimento EV, et al. Protein-tyrosine phosphatase PTPD1 regulates focal adhesion kinase autophosphorylation and cell migration. J Biol Chem. 2008;283:10919–29.

    CAS  Article  Google Scholar 

  8. 8.

    Ni F, Yu WM, Wang X, Fay ME, Young KM, Qiu Y, et al. Ptpn21 controls hematopoietic stem cell homeostasis and biomechanics. Cell Stem Cell. 2019;24:608–20.

    CAS  Article  Google Scholar 

  9. 9.

    Giannakis M, Hodis E, Jasmine Mu X, Yamauchi M, Rosenbluh J, Cibulskis K, et al. RNF43 is frequently mutated in colorectal and endometrial cancers. Nat Genet. 2014;46:1264–6.

    CAS  Article  Google Scholar 

  10. 10.

    Korff S, Woerner SM, Yuan YP, Bork P, von Knebel Doeberitz M, Gebert J. Frameshift mutations in coding repeats of protein tyrosine phosphatase genes in colorectal tumors with microsatellite instability. BMC Cancer. 2008;8:329.

    Article  Google Scholar 

  11. 11.

    Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB, et al. Recurrent R-spondin fusions in colon cancer. Nature. 2012;488:660–4.

    CAS  Article  Google Scholar 

  12. 12.

    Cardone L, Carlucci A, Affaitati A, Livigni A, DeCristofaro T, Garbi C, et al. Mitochondrial AKAP121 binds and targets protein tyrosine phosphatase D1, a novel positive regulator of src signaling. Mol Cell Biol. 2004;24:4613–26.

    CAS  Article  Google Scholar 

  13. 13.

    Carlucci A, Porpora M, Garbi C, Galgani M, Santoriello M, Mascolo M, et al. PTPD1 supports receptor stability and mitogenic signaling in bladder cancer cells. J Biol Chem. 2010;285:39260–70.

    CAS  Article  Google Scholar 

  14. 14.

    Rosenbluth MJ, Lam WA, Fletcher DA. Analyzing cell mechanics in hematologic diseases with microfluidic biophysical flow cytometry. Lab Chip. 2008;8:1062–70.

    CAS  Article  Google Scholar 

  15. 15.

    Fay ME, Myers DR, Kumar A, Turbyfield CT, Byler R, Crawford K, et al. Cellular softening mediates leukocyte demargination and trafficking, thereby increasing clinical blood counts. Proc Natl Acad Sci USA. 2016;113:1987–92.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Institutes of Health grants HL130995 and DK092722, and a St. Baldrick’s Foundation reseach grant (to C-KQ).

Author information

Affiliations

Authors

Contributions

LH, FN, and XW conducted mouse experiments and summarized the data. MEF performed microfluidics assays. KMY performed the Atomic Force Microscope measurements. WAL and TAS provided critical advice. C-KQ designed the experiments and directed the entire project. LH, FN, and C-KQ wrote the manuscript.

Corresponding author

Correspondence to Cheng-Kui Qu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hu, L., Ni, F., Wang, X. et al. Decreased cell stiffness enhances leukemia development and progression. Leukemia 34, 2493–2497 (2020). https://doi.org/10.1038/s41375-020-0763-7

Download citation

Further reading

Search

Quick links